Last reviewed · How we verify
NCT06826846
Comparison of the Analgesic Effects of Continuous Versus Single-Shot Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery
NA trial testing Serratus posterior superior intercostal plane block (single-shot) in Arthroscopic Shoulder Surgery in 90 participants. Completed in 10 October 2025.
15 September 2025
Quick facts
| Lead sponsor | Goztepe Prof Dr Suleyman Yalcın City Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 90 |
| Start date | 1 March 2025 |
| Primary completion | 15 September 2025 |
| Estimated completion | 10 October 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Serratus posterior superior intercostal plane block (single-shot)
- Serratus posterior superior intercostal plane block (catheter)
Conditions studied
- Arthroscopic Shoulder Surgery — all drugs for Arthroscopic Shoulder Surgery →
Sponsor
Goztepe Prof Dr Suleyman Yalcın City Hospital
Who can join
Adults 18 to 80, any sex, with Arthroscopic Shoulder Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients undergoing arthroscopic shoulder surgery often experience moderate to severe postoperative pain. Various medical treatments are employed to provide analgesia for these patients. The advancement of regional anesthesia techniques has made possible to both reduce the use of narcotic analgesics and provide long-term pain management benefits. The Serratus Posterior Superior Intercostal Plane Block (SPSIPB) was first described in 2023 by Serkan Tulgar et al. Cadaveric studies and dermatomal analyses in patients have demonstrated its ability to provide analgesia in the back, neck, shoulder, axilla, and lateral thoracic regions. Even though patients undergoing shoulder surgery benefit from the block; once the duration of a single-shot block wears off, they may experience severe pain again. The aim of this study is to investigate the analgesic effects of a single-shot SPSIPB compared to continuous infusion provided by placing a catheter in this region. The hypothesis of this study: In arthroscopic shoulder surgery, the continuous application of the serratus posterior superior intercostal plane block using a catheter will result in lower pain scores, reduced opioid consumption, and improved patient satisfaction compared to single-shot application.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06826846
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arthroscopic Shoulder Surgery
Currently open trials in the same condition.
- NCT07429669 — Comparative Analgesia and Respiratory Effects of Shoulder Blocks · NA · recruiting
- NCT07253740 — Interscalene Versus Infraspinatus-Teres Minor Blocks for Arthroscopic Shoulder Surgery · NA · recruiting
- NCT07090733 — Ultrasound Guided Interscalene, Suprascapular and Anterior Glenoid Nerve Blocks on Diaphragmatic Excursion and Analgesia · NA · recruiting
Other Goztepe Prof Dr Suleyman Yalcın City Hospital trials
Trials by the same sponsor.
- NCT06539923 — Sarcopenic Index and Related Factors in Patients With Type 2 Diabetes · completed
- NCT06386731 — Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice · NA · completed
- NCT06519903 — Anxiety Reduction in Type 2 Diabetes Through Breathing ExercisesPatients With Type 2 Diabetes · NA · completed
- NCT06229899 — Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals · completed
- NCT06228898 — Changes in Hematological Parameters With Glycemia Control in Type 2 Diabetes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06826846 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Goztepe Prof Dr Suleyman Yalcın City Hospital
- Last refreshed: 2 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06826846.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing